Interleukin-1 receptor antagonist gene polymorphism and Pseudomonas aeruginosa chronic infection in children with cystic fibrosis
K. Chadelat, H. Corvol, C. Flamant, M. Roussey, F. Bremont, A. Flahault, M. C. Miesch, A. Clement, A. Henrion-Caude (Paris, Rennes, Toulouse, France)
Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies
Session: Cystic fibrosis: new genes, new controversies
Session type: Oral Presentation
Number: 1131
Disease area: Paediatric lung diseases, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Chadelat, H. Corvol, C. Flamant, M. Roussey, F. Bremont, A. Flahault, M. C. Miesch, A. Clement, A. Henrion-Caude (Paris, Rennes, Toulouse, France). Interleukin-1 receptor antagonist gene polymorphism and Pseudomonas aeruginosa chronic infection in children with cystic fibrosis. Eur Respir J 2003; 22: Suppl. 45, 1131
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Polymorphisms of the IL-10 gene and pseudomonas aeruginosa infection in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006
Interleukin-6 gene variants are associated with early Pseudomonas infection in cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 727s Year: 2005
Susceptibility to chronic bacterial purulent rhinosinusitis is associated with the combination of interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphic alleles Source: Eur Respir J 2005; 26: Suppl. 49, 406s Year: 2005
Interleukin-1b and interleukin-1 receptor antagonist gene polymorphisms in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 136s Year: 2004
The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease Source: Eur Respir J 2014; 44: 1608-1615 Year: 2014
Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007
Association of IL-8 A-251T polymorphism with Pseudomonas aeruginosa infection and lung function decline in children with CF Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005
Chronic Pseudomonas aeruginosa lung infection, but not CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis Source: Virtual Congress 2021 – Adult cystic fibrosis Year: 2021
Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003
Single nucleotide polymorphisms in genes of the innate immunity in cystic fibrosis patients: correlation with lung function and pseudomonas aeruginosa (P.a.) colonisation Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017 Year: 2017
Antiapoptotic and proinflammatory function of toll-like receptor 2 in acute C. pneumoniae infection of COPD lung tissue Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006
Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients Source: Eur Respir J 2008; 31: 822-829 Year: 2008
Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021
Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis Source: Eur Respir J 2005; 26: 651-656 Year: 2005
TNF and LTA gene polymorphisms in cystic fibrosis patients with Burkholderia cepacia complex (Bcc) Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021
Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006
Toll-like receptor polymorphisms associated with progression of Mycobacterium tuberculosis infection to pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 142s Year: 2006